Drug Shortage Report for APPRILON
| Report ID | 222034 |
| Drug Identification Number | 02375885 |
| Brand name | APPRILON |
| Common or Proper name | DOXYCYCLINE (DOXYCYCLINE MONOHYDRATE) |
| Company Name | GALDERMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DOXYCYCLINE |
| Strength(s) | 40MG |
| Dosage form(s) | CAPSULE (IMMEDIATE AND DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 2 14-capsule blister cards (28 capsules) |
| ATC code | J01AA |
| ATC description | TETRACYCLINES |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-03-13 |
| Actual start date | 2024-03-13 |
| Estimated end date | 2024-03-22 |
| Actual end date | 2024-03-19 |
| Shortage status | Resolved |
| Updated date | 2024-03-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 COMMERCE VALLEY DRIVE WEST THORNHILL, ONTARIO CANADA L3T 7V9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-03-20 | English | Compare |
| v6 | 2024-03-19 | French | Compare |
| v5 | 2024-03-19 | English | Compare |
| v4 | 2024-03-14 | English | Compare |
| v3 | 2024-03-13 | French | Compare |
| v2 | 2024-03-13 | English | Compare |
| v1 | 2024-03-13 | English | Compare |
Showing 1 to 7 of 7